These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2879325)

  • 41. Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats.
    Bymaster FP; Hemrick-Luecke SK; Perry KW; Fuller RW
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):87-94. PubMed ID: 8935803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
    Cohen ML; Parli CJ; Fuller RW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1006-11. PubMed ID: 2600800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles.
    Perregaard J; Arnt J; Bøgesø KP; Hyttel J; Sánchez C
    J Med Chem; 1992 Mar; 35(6):1092-101. PubMed ID: 1348090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Further characterization of tolerance to the corticosterone-elevating effect of pergolide in rats.
    Gust CM; Fuller RW
    Neurosci Lett; 1988 Nov; 93(2-3):307-11. PubMed ID: 2907374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain.
    Fuller RW; Snoddy HD
    Life Sci; 1983 Dec; 33(23):2357-61. PubMed ID: 6645804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
    Robertson DW; Bloomquist W; Wong DT; Cohen ML
    Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine receptor modulation of corticosterone secretion in neonatal and adult rats.
    Kitchen I; Kelly M; Turner M
    J Pharm Pharmacol; 1988 Aug; 40(8):580-1. PubMed ID: 2907016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.
    Fuller RW; Hemrick-Luecke SK; Perry KW; Toomey RE
    J Pharm Pharmacol; 1985 Apr; 37(4):268-70. PubMed ID: 2860228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.
    Hamik A; Peroutka SJ
    Cancer Chemother Pharmacol; 1989; 24(5):307-10. PubMed ID: 2527092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Receptor interactions of dopamine and serotonin antagonists: binding in vitro and in vivo and receptor regulation.
    Leysen JE; Gommeren W; Janssen PF; Van Gompel P; Janssen PA
    Psychopharmacol Ser; 1988; 5():12-26. PubMed ID: 3045796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions of trazodone with serotonin neurons and receptors.
    Fuller RW; Snoddy HD; Cohen ML
    Neuropharmacology; 1984 May; 23(5):539-44. PubMed ID: 6429562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide.
    Fuller RW; Perry KW; Hemrick-Luecke SK
    Neurochem Res; 1982 Apr; 7(4):399-405. PubMed ID: 6125905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and 5HT-receptors affinity of some 4-phenylquinoline derivatives.
    Anzini M; Vomero S; Garofalo A; Cappelli A; Cagnotto A
    Farmaco; 1989 Jun; 44(6):555-63. PubMed ID: 2529861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pergolide: a dopamine agonist at both D1 and D2 receptors.
    Fuller RW; Clemens JA
    Life Sci; 1991; 49(13):925-30. PubMed ID: 1832202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotoninergic regulation of corticosterone secretion in domestic fowl.
    Cheung A; Hall TR; Harvey S
    J Endocrinol; 1987 May; 113(2):159-65. PubMed ID: 3585229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative 5-HT2-receptor antagonist activity of amesergide and its active metabolite 4-hydroxyamesergide in rats and rabbits.
    Cohen ML; Kurz KD; Fuller RW; Calligaro DO
    J Pharm Pharmacol; 1994 Mar; 46(3):226-9. PubMed ID: 8027933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors.
    Maziere B; Crouzel C; Venet M; Stulzaft O; Sanz G; Ottaviani M; Sejourne C; Pascal O; Bisserbe JC
    Int J Rad Appl Instrum B; 1988; 15(4):463-8. PubMed ID: 3255742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum corticosterone elevation by pergolide in rats: prevention of tolerance development by spiperone.
    Fuller RW; Snoddy HD
    J Pharm Pharmacol; 1982 Sep; 34(9):607-8. PubMed ID: 6127394
    [No Abstract]   [Full Text] [Related]  

  • 60. The central anti-serotonin activity of zotepine, a new neuroleptic, in rats.
    Shimomura K; Satoh H; Hirai O; Mori J; Tomoi M; Terai T; Katsuki S; Motoyama Y; Ono T
    Jpn J Pharmacol; 1982 Jun; 32(3):405-12. PubMed ID: 6125612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.